# Initiating Transdermal Estradiol Therapy in Turner's Syndrome

> **NCT00870220** · PHASE1 · TERMINATED · sponsor: **University of Chicago** · enrollment: 1 (actual)

## Conditions studied

- Turner's Syndrome

## Interventions

- **DRUG:** Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch

## Key facts

- **NCT ID:** NCT00870220
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2014-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870220, "Initiating Transdermal Estradiol Therapy in Turner's Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00870220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*